Sean Bohen, Olema Oncology CEO
Olema Oncology receives $180M in total funding
Olema Oncology, the Bay Area biotech run by former AstraZeneca executive Sean Bohen, raised $130 million from a private placement and a credit facility of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.